Therapy Intelligence™
More than a syndicated study, Therapy Intelligence transforms how life sciences companies understand treatment reality, translating physician decisions, patient journeys and competitive dynamics into strategic clarity.
Therapy Intelligence
Built on Real Clinical Practice
Leveraging real-world patient data, our Therapy Intelligence solution provides fast, robust, multi-country insights. Beyond the data, our experts partner with your team to interpret findings, identify strategic implications, and turn insights into action.
Immediate access
High-quality market evidence, ready now.
Answers in weeks, not months
No study from scratch
Skip months of study design and fieldwork.
Less effort, more impact
Therapy-specific insights
Focused on your indication, not generic market data.
Tailored to your market
Decision-ready evidence
Built to support confident business decisions.
Made to act on
How It Works
Four Intelligence Engines,
One Connected View
Scientific
Built with clinicians and disease experts around the real clinical questions that determine treatment decisions.
Built on clinical reality, not assumptions
Real-World
Powered by physician-reported patient records, capturing the full complexity of treatment pathways.
Observed patients not proxy data
Adaptative
Study content evolves in response to market dynamics.
Built to adapt, not just to report
Actionable
Identifying adoption barriers, treatment gaps and priority patient and HCP segments
Insight built to be acted on
Coverage
Therapeutic Areas We Cover
One intelligence framework delivering actionable evidence across complex, high-stakes therapy areas where strategic decisions matter most.
Hematology
Multiple Myeloma
DLBCL
CLL
Follicular Lymphoma
Solid Tumors
HER2+ Breast Cancer
Endometrial Cancer
Ovarian Cancer
Prostate Cancer
Immunology
Asthma
COPD
EGPA
IBD
Psoriasis
Emerging Therapies
Obesity
HCL
Strategic use cases
Turning Insight Into Strategic Decisions
Each growth lever maps to a concrete commercial decision your team needs to make, supported by data from the field.
01
Identify Growth Opportunities
Pinpoint untapped patient segments, under-treated eligible pools and white-space opportunities before your competitors do.
e.g. Under-treated pools in later lines of therapy
02
Refine Your Positioning
See precisely where your brand wins, where it stalls, and how the competitive frame should evolve as the landscape shifts.
e.g. Positioning versus emerging cell & gene therapies
03
Activate the Right HCPs
Identify over- and under-performing physicians with granular segmentation to unlock targeted adoption opportunities.
e.g. Hematologist segments slower to adopt new regimens
04
Anticipate Market Evolution
Track launches, sequence changes, access shifts and new prescriber behaviours earlier, before they move the market.
e.g. Shifting treatment sequencing as new therapies launch
Methodology
Built On Clinical Reality, Not Assumptions
Every Therapy Intelligence dataset is co-designed with leading clinicians, drawing on structured physician interviews and longitudinal patient record analysis. The result is insight that reflects actual prescribing behaviour, not survey proxies.
Study design
Co-designed with leading physicians in each therapeutic area
Expert teams
Dedicated pods of specialist analysts with deep, hands-on experience in a specific indication
Data collection
Structured interviews + real patient record abstraction
Analysis
Clinical and statistical validation with peer-review standards
Output
Publication-ready insights tailored to your strategic questions
1k+
HCPs interviewed
1k+
Patients profiled
1+
Countries covered
1+
Available indications
Ready To See What Therapy Intelligence™ Reveals For Your Brand?
Paul Taylor
Strategic Partnership Director
Manuel Guzman Martin
Global Vice President Commercial
Mélanie Marrot, PhD
Vice President Commercial France
